With the start of a new school year and the approaching winter, it’s time to get informed about the most critical information regarding the 2016/17 influenza vaccines and CDC’s vaccination recommendations.
Join us on October 10th!
October 10th, 6:00-7:00 PM, EST
Tune in here.
Join us for a live Ask the Expert session with Memorial Sloan Kettering Cancer Center’s Chau T. Dang, MD. She will discuss advances... [...]
The treatment combination consisting of Cotellic® (cobimetinib) plus Zelboraf® (vemurafenib) improves overall survival for patients with advanced, BRAF (V600) mutation-positive melanoma. These confirmatory... [...]
In 2016, the American Cancer Association estimates that 22,280 women will be diagnosed with ovarian cancer, and 14,240 women will die from the disease. The incidence of ovarian cancer has decreased slightly... [...]
Your story matters. Head and neck cancer is a challenging diagnosis, connecting with others who have had to deal with the side effects of treatment and the challenges of treatment decision making is an... [...]
The U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for Keytruda® (pembrolizumab) for first-line treatment of patients with advanced non-small cell lung cancer (NSCLC).
It depends: there are many kinds of pneumonia, some of which are preventable, especially in older individuals. Pneumonia is a common lung infection caused by bacteria, a virus or fungi and is more common... [...]
Obesity almost always increases cancer risk and worsens outcomes, but researchers led by scientists at Dana-Farber Cancer Institute report that overweight patients with advanced kidney cancer had significantly... [...]
The information contained above is general in nature and is not intended as a guide to self-medication by consumers or meant to substitute for advice provided by your own physician or other medical professional. The reader is advised to consult with a physician or other medical professional and to check product information (including packaging inserts) for changes and new information regarding dosage, precautions, and contra indication before administering any drug, herb, supplement, compound, therapy or treatment discussed herein. Neither the editors nor the publisher accepts any responsibility for the accuracy of the information or consequences from the use or misuse of the information contained herein.